Product
Nicorandil
8 clinical trials
15 indications
Indication
DementiaIndication
Mild Cognitive ImpairmentIndication
Type 2 Diabetes MellitusIndication
ST Elevation Myocardial InfarctionIndication
AngioplastyIndication
Diabetes MellitusIndication
Type 2Indication
Coronary Artery DiseaseIndication
End-Stage Renal DiseaseIndication
Coronary Artery Bypass GraftIndication
Radial Artery GraftsIndication
Antispastic TherapyIndication
Pilot StudyIndication
Insulin ResistanceIndication
No-Reflow PhenomenonClinical trial
Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging: SMArT-HSStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
Clinical Study Evaluating the Nephroprotective Effect of Nicorandil in Patients With Type 2 Diabetes MellitusStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
Impact of Intravenous Administration of Nicorandil as Adjuncts to Reperfusion Treatment for Acute ST Segment Elevation Myocardial Infarction: a Multi-center Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
Clinical Study Evaluating the Effect of Nicorandil in Type 2 Diabetic Obese Patients Treated With SulfonylureaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Effects of Nicorandil on Cardiovascular Events in Patients With Coronary Artery Disease Receiving HemodialysisStatus: Active (not recruiting), Estimated PCD: 2011-06-01
Clinical trial
Effect of Nicorandil, Diltiazem or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts - A Pilot Randomized Controlled TrialStatus: Completed, Estimated PCD: 2023-02-02
Clinical trial
Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development in Healthy and Insulin Resistant SubjectsStatus: Completed, Estimated PCD: 2020-01-01
Clinical trial
A Randomized, Open Label, Parallel-group Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery DiseaseStatus: Recruiting, Estimated PCD: 2024-07-01